From the Food and Drug Administration.
Nightingale
S L
SL
D000280:Administration, Inhalation; D016907:Adverse Drug Reaction Reporting Systems; D000701:Analgesics, Opioid / Q000009:adverse effects*; D000970:Antineoplastic Agents; D004348:Drug Labeling; D015507:Drugs, Investigational; D018166:Health Care Reform; D006801:Humans; D008495:Medical Oncology / Q000639:trends; D009369:Neoplasms / Q000628:therapy*; D009538:Nicotine / Q000008:administration & dosage* / Q000627:therapeutic use; D016540:Smoking Cessation; D014147:Tramadol / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration
D000701:Analgesics, Opioid; D000970:Antineoplastic Agents; D015507:Drugs, Investigational; D014147:Tramadol; D009538:Nicotine